{
    "2018-10-31": [
        [
            {
                "time": "2018-11-15",
                "original_text": "Sandoz Receives FDA Approval For Biosimilar Hyrimoz",
                "features": {
                    "keywords": [
                        "FDA",
                        "Approval",
                        "Biosimilar",
                        "Hyrimoz"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "GlaxoSmithKline plc (GSK) Q3 Earnings Conference Call Transcript",
                "features": {
                    "keywords": [
                        "Q3",
                        "Earnings",
                        "Conference Call",
                        "Transcript"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-14",
                "original_text": "Premier Bay Area biotech developer tees up next major project",
                "features": {
                    "keywords": [
                        "Bay Area",
                        "biotech",
                        "developer",
                        "major project"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-24",
                "original_text": "Amgen (AMGN) Beats on Earnings & Sales in Q3, Raises View",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Earnings",
                        "Sales",
                        "Raises View"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "Aduro (ADRO) Q3 Loss Narrower Than Expected, Revenues Lag",
                "features": {
                    "keywords": [
                        "Aduro",
                        "Q3",
                        "Loss",
                        "Narrower",
                        "Revenues Lag"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-12",
                "original_text": "FDA approves Novartis' copy of AbbVie bestseller Humira",
                "features": {
                    "keywords": [
                        "FDA",
                        "approves",
                        "Novartis",
                        "Humira"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-25",
                "original_text": "Glaxo (GSK) Beats Earnings Estimates in Q3, Revenue In-line",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Earnings",
                        "Estimates",
                        "Revenue In-line"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-08",
                "original_text": "Novartis May Beat Ironwood Pharmaceuticals to the Punch",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Ironwood",
                        "Pharmaceuticals",
                        "Beat"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "Aging Blockbusters Send Amgen Inc.'s Bottom Line Lower",
                "features": {
                    "keywords": [
                        "Aging",
                        "Blockbusters",
                        "Amgen",
                        "Bottom Line Lower"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "Aging Blockbusters Send Amgen Inc.&apos;s Bottom Line Lower",
                "features": {
                    "keywords": [
                        "Aging",
                        "Blockbusters",
                        "Amgen",
                        "Bottom Line Lower"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}